Cameron Health’s Subcutaneous ICD Gains FDA Panel Endorsement
Following the panel vote April 26, Cameron CEO Kevin Hykes told “The Gray Sheet” that the company expects to receive PMA approval in the first half of 2013, as previously anticipated.
Following the panel vote April 26, Cameron CEO Kevin Hykes told “The Gray Sheet” that the company expects to receive PMA approval in the first half of 2013, as previously anticipated.